Doutor Nichires Holdings Co., Ltd. (JP:3087)
:3087
Want to see JP:3087 full AI Analyst Report?
Top Page
Doutor Nichires Holdings Co., Ltd.
(3087)
Select Model
Select Model
Rating:72Outperform
Price Target:
¥2,858.00
▲(10.01% Upside)
Action:Reiterated
Date:04/16/26
The score is driven primarily by strong financial stability (minimal leverage) and improving profitability, partially offset by inconsistent cash flow generation. Technical indicators suggest weak near-term momentum, while valuation appears fair with a moderate dividend yield.
Positive Factors
Conservative balance sheet
Extremely low leverage gives durable financial flexibility: the company can fund operations, absorb shocks, and pursue selective investments or store-level refurbishments without stressing credit lines. This conservatism supports resilience through economic cycles over the next 2–6 months.
Negative Factors
Volatile cash generation
Inconsistent operating cash flow and weak cash conversion reduce the firm's ability to self-fund investments, smooth dividends, or rapidly scale initiatives. The volatility implies working-capital or reinvestment needs that could constrain flexibility in the coming 2–6 months.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet
Extremely low leverage gives durable financial flexibility: the company can fund operations, absorb shocks, and pursue selective investments or store-level refurbishments without stressing credit lines. This conservatism supports resilience through economic cycles over the next 2–6 months.
Read all positive factors
Doutor Nichires Holdings Co., Ltd. (3087) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥118.37B
Dividend Yield2.09%
Average Volume (3M)126.76K
Price to Earnings (P/E)15.5
Beta (1Y)0.36
Revenue Growth6.94%
EPS Growth8.70%
CountryJP
Employees2,765
SectorConsumer Cyclical
Sector Strength84
IndustryRestaurants
Share Statistics
EPS (TTM)150.50
Shares Outstanding45,609,760
10 Day Avg. Volume95,670
30 Day Avg. Volume126,763
Financial Highlights & Ratios
PEG Ratio2.00
Price to Book (P/B)1.21
Price to Sales (P/S)0.80
P/FCF Ratio65.92
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)187.99
Revenue Forecast (FY)¥165.60B
Doutor Nichires Holdings Co., Ltd. Business Overview & Revenue Model
Company Description
DOUTOR NICHIRES Holdings Co., Ltd. is a diversified Japanese enterprise primarily engaged in operating a network of restaurants and cafes across the nation. Beyond its food service establishments, the company boasts a robust manufacturing arm, pro...
How the Company Makes Money
Doutor Nichires Holdings Co., Ltd. generates revenue through its coffee shop operations, where it earns income from the sale of coffee, beverages, and food items. The company also derives revenue from franchise fees, as it operates numerous franch...
Doutor Nichires Holdings Co., Ltd. Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
92
Very Positive
Cash Flow
62
Positive
| Breakdown | TTM | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 151.23B | 159.15B | 148.82B | 140.63B | 126.86B | 109.36B |
| Gross Profit | 90.45B | 93.69B | 89.62B | 84.19B | 74.77B | 64.31B |
| EBITDA | 14.03B | 14.82B | 14.20B | 11.58B | 6.88B | 2.40B |
| Net Income | 6.58B | 7.23B | 6.88B | 5.49B | 3.43B | 1.22B |
Balance Sheet | ||||||
| Total Assets | 133.54B | 136.52B | 134.23B | 127.79B | 121.04B | 118.23B |
| Cash, Cash Equivalents and Short-Term Investments | 33.34B | 29.42B | 38.99B | 35.80B | 32.22B | 34.55B |
| Total Debt | 2.04B | 2.08B | 2.11B | 2.77B | 2.03B | 1.54B |
| Total Liabilities | 32.33B | 30.96B | 29.88B | 28.31B | 24.74B | 24.11B |
| Stockholders Equity | 100.86B | 105.18B | 104.00B | 99.16B | 96.02B | 93.86B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.93B | 6.49B | 7.33B | 142.00M | 10.43B |
| Operating Cash Flow | 0.00 | 7.02B | 12.35B | 11.79B | 5.17B | 14.64B |
| Investing Cash Flow | 0.00 | -10.81B | -6.23B | -4.90B | -5.59B | -4.93B |
| Financing Cash Flow | 0.00 | -8.42B | -2.93B | -3.37B | -1.98B | -1.50B |
Doutor Nichires Holdings Co., Ltd. Technical Analysis
Negative
2598.00
Price Trends
2802.30
Negative
2840.76
Negative
2686.75
Negative
Market Momentum
-44.43
Negative
46.67
Neutral
82.31
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3087, the sentiment is Negative. The current price of 2598 is below the 20-day moving average (MA) of 2692.50, below the 50-day MA of 2802.30, and below the 200-day MA of 2686.75, indicating a bearish trend. The MACD of -44.43 indicates Negative momentum. The RSI at 46.67 is Neutral, neither overbought nor oversold. The STOCH value of 82.31 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:3087.
Doutor Nichires Holdings Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥118.37B | 15.52 | ― | 2.09% | 6.94% | 8.70% | |
68 Neutral | ¥126.72B | 19.30 | ― | 1.88% | 21.61% | 11.23% | |
65 Neutral | ¥260.61B | 21.63 | 9.66% | 0.55% | 15.12% | 18.16% | |
63 Neutral | ¥112.24B | 24.51 | ― | 0.70% | 6.85% | 45.60% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥626.31B | 34.96 | 9.53% | 0.55% | 12.02% | 20.18% | |
58 Neutral | ¥120.64B | 21.62 | 9.66% | 1.17% | 8.30% | 5.03% |
* Consumer Cyclical Sector Average
JP:3087
Doutor Nichires Holdings Co., Ltd.
2,677.00
54.35
2.07%
JP:8179
Royal Holdings Co
1,236.00
-14.58
-1.17%
JP:3197
Skylark Holdings Co
2,753.00
-304.78
-9.97%
JP:7581
Saizeriya Co
5,340.00
247.58
4.86%
JP:3543
KOMEDA Holdings Co., Ltd.
2,740.00
-163.72
-5.64%
JP:8153
MOS FOOD SERVICES, INC.
3,640.00
-48.59
-1.32%
Doutor Nichires Holdings Co., Ltd. Corporate Events
Doutor-Nichires to Grant ¥138 Million in Restricted Stock to Directors
May 27, 2026
Doutor-Nichires Holdings has approved the disposal of 52,100 treasury shares as restricted stock, valued at about ¥138.7 million, to compensate seven directors of the parent company and nine directors of its subsidiaries. The shares will be i...
Doutor Nichires Raises Year-End Dividend as Profit Tops Forecasts
Apr 14, 2026
Doutor Nichires Holdings has announced a year-end dividend of ¥30 per share for the fiscal year with a record date of February 28, 2026, up from ¥27 in the previous year and slightly above its earlier forecast of ¥29. This brings th...
DOUTOR·NICHIRES Lifts Earnings and Dividends, Signals Continued Growth in FY2027
Apr 14, 2026
DOUTOR·NICHIRES Holdings reported consolidated net sales of ¥159.1 billion for the fiscal year ended February 28, 2026, up 6.9% year on year, with operating profit rising 5.8% to ¥10.1 billion and profit attributable to owners of pa...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.